Cell and Gene therapy is one of the most important new therapeutic modalities but it is still at an early stage of development.
Reducing manufacturing costs, increasing patient safety, control of process variabilities and improved process robustness are some of the key challenges that need to be addressed in order to make these new exiting therapies available to a wider population.
The Flexible Modular Automation Platform (FMAP) is an innovative platform that helps to meet these challenges.
THE BENEFITS of FMAP:
It INTEGRATES and UNIFIES the interfaces of different process equipment to provide simplified control to the operators.
It provides a higher level of AUTOMATION to reduce the risks of human error and to keep CQAs within acceptable limits.
It supports PAT and real-time product releases.
It REDUCES manufacturing COSTS.
LEARN MORE ABOUT HOW YOU CAN BENEFIT FROM USING FMAP.
FILL IN THE FORM AND DOWNLOAD YOUR COPY OF PRESENTATION.
I am interested in:
By clicking submit below, you consent to allow TRAC to store and process the personal information submitted above to provide you the content requested. For more information please review our Privacy Policy.
A NEW STANDARD FOR DATA AND PROCESS CONTROL
FMAP integrates different process equipment into a unified platform that simplifies the management and control of production processes.
It is the perfect solution for flexible and modular production processes.
DISCOVER THE MANY OPTIONS THAT THE PLATFORM ENABLES AND THE TECHNOLOGY BEHIND IT.
WANT TO KNOW MORE?
GET IN TOUCH WITH US AT INFO@TRAC.SI AND REQUEST A VIDEO DEMONSTRATION.